BERGEM·HEALTH
Home Doctors Assoc. Prof. Dr. Erkan Kayıkçıoğlu, MD
MEDICAL ONCOLOGY · LIV BAHÇEŞEHIR

Assoc. Prof. Dr. Erkan Kayıkçıoğlu, MD

Associate Professor of Medical Oncology · İSÜ Liv Hospital Bahçeşehir
Assoc. Prof. Dr. Erkan Kayıkçıoğlu is a medical oncologist at İSÜ Liv Hospital Bahçeşehir. After his MD from the English-language program at Hacettepe University and internal medicine specialization at Selçuk University Meram Faculty of Medicine, he completed a medical oncology fellowship at the University of Health Sciences Antalya Training and Research Hospital. He has held faculty positions at Recep Tayyip Erdoğan University and Süleyman Demirel University Faculty of Medicine. He is a member of ESMO and the Turkish Medical Oncology Association.
Specialties: Oncology
10+
years in oncology
20+
peer-reviewed publications
ESMO Member
European Society for Medical Oncology
ESMO MemberImmunotherapyBreast CancerLung CancerPersonalized OncologyClinical Trials
A BergemHealth coordinator arranges contact with the professor within 24–48 hours on business days.
Direct contract with BergemHealth
CONSULTATION LANGUAGES
TR Turkish · native
EN English · professional
RU Russian · via BergemHealth coordinator
UK Ukrainian · via BergemHealth coordinator
ISTANBUL · 06/2026
EDUCATION & CAREER

Timeline

Career milestones.

2010-2013
Internal Medicine Specialist
Seydişehir State Hospital
2013-2015
Internal Medicine Specialist
Antalya Private Life Hospital
2015-2018
Medical Oncology Fellow
University of Health Sciences Antalya Training and Research Hospital
2018-2020
Medical Oncology Specialist
Recep Tayyip Erdoğan University Faculty of Medicine
2020-2021
Medical Oncology Specialist
University of Health Sciences Antalya Training and Research Hospital
2021-2023
Lecturer
Süleyman Demirel University Faculty of Medicine
2023-present
Medical Oncology Specialist
Beylikdüzü Kolan Hospital / İSÜ Liv Hospital Bahçeşehir
PUBLICATIONS

Scientific work

Selected peer-reviewed publications.

  • 2023
    Medicine (Baltimore)
    «The role of claudin 18.2 and HER-2 in pancreatic cancer outcomes»
    · first author
  • 2023
    World J Gastrointest Oncol
    «Prognostic value of claudin 18.2 expression in gastric adenocarcinoma»
    · first author
  • 2023
    Cureus
    «A novel prognostic index for metastatic colon cancer: the prognostic immune nutritional index»
    · first author
  • 2023
    J Cancer Res Clin Oncol
    «Potential drug-drug interactions in patients with non-small cell lung cancer at a university hospital in Turkey»
    · co-author
  • 2022
    J Contemp Med
    «Prognostic value of clinicopathological characteristic of patients with malign mesothelioma at Mediterranean region of Turkey»
    · first author
  • 2022
    Turk J Clin Lab
    «Selçuk Üniversitesi Meram Tıp Fakültesi sağlık çalışanlarında fonksiyonel gastrointestinal bozuklukların Roma III kriterleri eşliğinde sıklığı ve birlikteliğinin belirlenmesi»
    · first author
REQUEST

Tell me about your case — I’ll read it personally.

Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.

Open the consultation form
  • Reply within 4 hours during business hours
  • Confidentiality guaranteed
  • Coordinator-translator inside the doctor’s office
  • Tumour board of 2–3 professors within 72 hours